SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010266
Filing Date
2020-08-11
Accepted
2020-08-11 07:42:56
Documents
87
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20200630x10q.htm 10-Q 1809718
2 EX-31.1 aplt-20200630ex311751ed8.htm EX-31.1 8229
3 EX-31.2 aplt-20200630ex3124c0970.htm EX-31.2 8461
4 EX-32.1 aplt-20200630ex321c3c56f.htm EX-32.1 5761
5 EX-32.2 aplt-20200630ex32201d331.htm EX-32.2 5906
  Complete submission text file 0001558370-20-010266.txt   7837365

Data Files

Seq Description Document Type Size
6 EX-101.INS aplt-20200630.xml EX-101.INS 1694287
7 EX-101.SCH aplt-20200630.xsd EX-101.SCH 68524
8 EX-101.CAL aplt-20200630_cal.xml EX-101.CAL 53771
9 EX-101.DEF aplt-20200630_def.xml EX-101.DEF 244625
10 EX-101.LAB aplt-20200630_lab.xml EX-101.LAB 531730
11 EX-101.PRE aplt-20200630_pre.xml EX-101.PRE 445300
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 201091071
SIC: 2834 Pharmaceutical Preparations